To identify possible neurotransmitters in the visual cortex, high pressure liquid chromatography was used to measure the release of endogenous compounds from a tissue slice preparation of the visual cortex of the rat. When synaptic release was induced, either by raising the K+ concentration in the medium or by adding veratridine, of the compounds measured, marked increases (6-to 35-fold) in release rate were observed for aspartate, glutamate, and y-aminobutyric acid (GABA). This increased release was blocked either with a low Ca"+/high Mg2+ or a tetrodotoxin-containing medium. To label possible aspartate or glutamate pathways, D-[3H]aspartate and D-["HIglutamate were injected in the lateral geniculate nucleus (LGN), superior colliculus, and visual cortex. Following injections in the LGN, labeling was observed in the pyramidal cells in cortical layer 6 and in a diffuse band in layer 4, whereas no cortical cells were labeled after injections in the superior colliculus. When D-["Hlaspartate was injected in the cortex, the uptake again was concentrated in the layer 6 cells, but no labeled cell bodies were seen in the LGN, confirming the specificity of the uptake and retrograde filling process. Diffuse labeling was present in the LGN, however, presumably produced by anterograde transport from the layer 6 cells.
, the identity of the transmitters used by other cells has not been established. Previous studies have suggested that, in addition to GABA, aspartate and glutamate may play a role as transmitters in cerebral cortex (see "Discussion"). In the present study, we have obtained further evidence that these compounds may have a neurotransmitter function, based on release of the endogenous compounds, and we have found that cells associated with aspartate and glutamate participate in the recurrent pathway from the cortex to the LGN. A preliminary report of this work has been published (Baughman and Gilbert, 1980) .
Materials and Methods
Tissue slices. Tissue slices from rat visual cortex were prepared in the following manner. Rats were decapitated after cervical dislocation and blocks of visual cortex, approximately 3 x 4 mm, were removed and placed in a 0.9% agarose/Kreb's solution at 37°C. Each block was placed on the stage of a Sorvall tissue chopper in a 4°C cold room, and when the agar had hardened, slices of 200-pm thickness were sectioned. The slices, approximately 30 mg, wet weight, were suspended in an Earle's salt solution (143 mM Na+, 5 mM K+, 1.8 mM Ca2', 0.8 mM Mg2+, 125 InM Cl-, 26 mM HCOa-, 1.0 mM HzPOd-, 0.8 mM Sod"-, 5.5 mM glucose), gassed with 5% COa, 95% Vol. 1, No. 4, Apr. 1981 air (pH 7.4) in a 37°C shaker bath, and incubated in a series of buffers of 5 ml each with changes every 5 min. For the high potassium-stimulated release experiments, the slices were incubated with three consecutive 5-min changes of normal medium followed by a 5-min "stimulated" incubation in high potassium (50 mM K+, 98 mM Na+) medium. For the control release experiments, the slices were incubated with two 5-min changes of normal medium, followed by a 5-min incubation in low calcium (0.1 mM Ca"+, 10 mM Mg'+, 132 mM Na+) medium and a 5-min "control" incubation in high potassium, low calcium (50 mM K+, 0.1 mM Ca"+, 10 mM Mg'+, 87 mM Na+) medium. For the veratridine-stimulated release experiments, the slices were incubated with three consecutive 5-min changes of normal medium followed by a 5-min "stimulated" incubation in normal medium containing 100 PM veratridine. In this case, for the control release experiments, the slices were incubated with two 5-min changes of normal medium followed by a 5-min incubation in normal medium containing 10 pM tetrodotoxin and a 5-min "control" incubation in normal medium containing 100 pM veratridine and 10 pM tetrodotoxin. All buffer solutions contained 1 pM n-leucine as an internal standard. Rates of release, normalized to the weight of the tissue and the internal standard, were determined for 18 amino acids and the ratio of the rates of release were calculated for the "stimulated" versus "control" fractions.
Analysis of release. At the end of the incubation series, the sections were weighed, and the fractions from each buffer change were frozen in liquid nitrogen and lyophilized. For desalting, the residue was extracted with 4 ml of 5% 6 N HCl in acetone; after centrifugation, the supernatant was extracted with 8 ml of iso-octane, followed by 4 ml of diethyl ether. For analysis, an aliquot of the aqueous extract was taken to dryness with N2 and reconstituted in 0.2 N Na' buffer (pH 2.2).
The compounds present in the final extract were analyzed on a high pressure liquid chromatograph (HPLC) with a sulfonated divinylbenzene polystyrene cation exchange column (Dionex DC-5A resin in a 4 mm x 15 cm stainless steel column) with o-phthalaldehyde (Benson and Hare, 1975) fluorescence detection. This procedure is capable of detecting compounds containing primary amino groups, such as amino acids and many peptides. Quantitation was based on peak heights compared with the n-leucine internal standard. All release rates were corrected for differences in response and recovery.
Localization experiments. All of the localization experiments were done on cats. The tracers used were D-["Hlaspartate and D-["HIglutamate, intended to be labels for acidic amino acid pathways (Streit, 1980) . Cats were anesthetized, paralyzed, held in a stereotaxic apparatus, and maintained on a respirator. The receptive field properties of cells at the injection sites were determined by extracellular recording and stimulation with a hand-held projector on a tangent screen. The labeled compound (20 to 200 PCi in 0.5 to 1 ~1 of buffered saline) then was pressure injected from the recording pipette . The cat was resuscitated and, after 1 to 2 days, re-anesthetized and perfused with a fixative containing 2% glutaraldehyde and 1% formaldehyde in a phosphate buffer, pH 7.4. Blocks of brain were removed, allowed to sink in a 30% sucrose solution of the above fixative, and sectioned on a freezing microtome. The sections then were processed for autoradiography. This technique was used to make injections of D- ["H] (Parikh et al., 1957) . Veratridine was obtained from Sigma Chemical Co. and tetrodotoxin was from Calbiochem.
Results
Tissue slice release. A trace of an HPLC analysis of the endogenous, primary amino-containing compounds in the tissue slices is shown in Figure la . The concentrations observed are similar to those reported previously (Tallan et al., 1954) . Although some of these compounds may be neurotransmitters of specific cell types, many clearly represent normal constituents of all tissues. Two independent means of depolarizing the tissue, intended to induce synaptic release, were used to determine which of the above compounds may act as neurotransmitters. Control experiments were carried out in the presence of the appropriate blocking agents in both cases. In the first procedure, the release in the presence of elevated K' and normal Ca" was compared with that observed with elevated Kt and low Ca'+/high Mg'+, which should block synaptic release. We refer to release in the first medium as stimulated release and release in the second medium as control release. Figure 1 , b and c, shows HPLC traces of the release patterns obtained with the two media; in Table I , the release rates for identified compounds are shown; and Figure 2 gives the ratios for stimulated/ control release for these compounds. The release rates of aspartate, glutamate, and GABA are enhanced markedly, while those of the other compounds measured are relatively unchanged. For aspartate, the release rate increased 12-fold; for glutamate, it increased 14-fold; and for GABA, it increased 6-fold. With normal medium, with medium containing low Ca"+/high Mg'+ and normal K', and with medium containing low Ca"/high Mg"+ and high K', the release rates were similar (data not shown). In the second procedure, the release was induced by 100 pM veratridine, which is known to open the voltagesensitive Na' channels, and for the control, the release was blocked with 10 pM tetrodotoxin, a Na+ channel blocker. The release rates obtained with this procedure also were increased most dramatically for aspartate, glutamate, and GABA as shown in Table II . The ratios for stimulated/control release are given in Figure 3 .
It is of interest to note that, with either stimulation procedure, there was a much less marked increase in the release of taurine or glycine which also have been proposed as possible cortical transmitters (Curtis and Johnston, 1974) . The resolution and the sensitivity of the Thr Set Gin principle, cortical cells having locally ramifying axons by making intracortical injections or label cells with distant projections by making the injections in their efferent targets. All cortical neurons have terminals in the immediate cortical area, and some, notably the pyramidal and spiny stellate cells, also project to distant sites. Injections of the labeled compounds were made in area 17 (the primary visual cortex) and in other regions with particularly heavy interconnections with it, including the LGN, superior colliculus, and area 19 (see the introduction for a brief description of these pathways). The most striking result was that obtained after the LGN injection (Fig. 4) . In the topographically appropriate region, many pyramidal cells in cortical layer 6 were labeled and there was a diffuse band of label in layer 4. Injection of D-[3H]glutamate produced a similar result (Fig. 5) , although the background labeling was heavier and it was difficult to distinguish a band of label in layer 4. In marked contrast to these results, injections of either labeled compound in the dorsal layers of the superior colliculus, the site of projection of cortical layer 5 cells, produced no labeling at all in the visual cortex. After injections of D-[3H]aspartate in area 19, there were a few labeled cells in the superficial layers of area 17. Thus, of the cells participating in the principal efferent pathways of the visual cortex, the layer 6 cells appear to be associated most strongly with uptake and transport of n-aspartate and n-glutamate.
Further evidence for the association of layer 6 pyramidal cells with uptake of aspartate and glutamate was obtained by making D-[3H]aspartate injections directly in area 17 and observing the local labeling pattern (Fig.  6a) . In the region of cortex immediately surrounding the injection site, labeled cells were found predominantly in the deeper layers, with the highest concentration in layer 6. Although there was heavy background labeling due to Gly Alo Val ,Leu Leu Tyr Phe pAlaG,b Figure   2 . Ratios of the rates of release of endogenous amino acids for potassiumstimulated versus low calcium control conditions (from Table I ). the injection, a diffuse band of label was visible in layer 4. A similar pattern was observed following a local injection into area 19 (Fig. 6~) . From previous results , it is known that layer 6 cells in area 19 project not only to the thalamus but to area 17 as well. In fact, a few cells in layer 6 of area 19 were labeled after the injection of D-[3H]aspartate in area 17.
The present series of experiments also made it possible to test for the existence of aspartate-and glutamateaccumulating cells in the subcortical visual pathways. For example, in the LGN, we were unable to label cells either with local injections (Fig. 7, a to c) or with retrograde filling following cortical injections (Fig. 8, a to d) . With local injections in the superior colliculus, on the other hand, there were numerous labeled cells through- (Fig. 8a) . This is unlikely to be due to retrograde transport because of the absence of cell body labeling in the LGN and instead must represent labeling of the corticogeniculate terminals originating from the cells in layer 6. On the other hand, following cortical injections, there was no label in the colliculus at the site of projection of the cortical layer 5 cells.
Discussion
The present results provide evidence that aspartate and glutamate may act as transmitters in the visual cortex, in particular, for the cells in layer 6. The first suggestion that these compounds might be involved in vertebrate central synaptic transmission came from the observation that they excite most cortical neurons (Hayashi, 1954; Krnjevic and Phillis, 1963) . Later studies showed that they are released from the cortical surface upon electrical stimulation in various subcortical areas (Jasper and Koyama, 1969) or by application of potassium to the cortex (Clark and Collins, 1976) . Electrically induced release of endogenous compounds from tissue slices of olfactory cortex also has suggested a role for either glutamate (Bradford and Richards, 1976) or aspartate (Collins, 1979) as a transmitter in the lateral olfactory tract. High affinity uptake systems, which may be associated with neurotransmitter inactivation, have been demonstrated for aspartate and glutamate in synaptosomal (Logan and Snyder, 1972) and slice preparations (Balcar and Johnston, 1972) of rat cerebral cortex.
In the present investigation, with tissue slices from I Glu G'Y Ala Vol iteu Leu Tyr Phe pAla Figure   3 . Ratios of the rates of release of endogenous amino acids for veratridinestimulated versus tetrodotoxin control conditions (from Table II ). visual cortex, we have demonstrated that, of 18 amino acids that were detectable, the release of aspartate, glutamate, and GABA was increased markedly with chemical depolarization. Two independent means of depolarizing the tissue were used, elevated extracellular K+ and veratridine. Increasing extracellular K' should depolarize glia as well as neurons, but the requirement that induced release be blocked in low Ca2'/high Mg2+ medium increases the likelihood that the observed release is synaptic in origin and is not a nonspecific release simply related to membrane depolarization. With veratridineinduced release, compared with K'-stimulated release, the ratio of stimulated to control release was similar for aspartate but higher for glutamate and GABA. As can be seen from Tables I and II , this effect was caused by a decrease in the release of glutamate and GABA in the tetrodotoxin control experiment. It is unclear whether this result has any functional significance, but it does indicate that the release of aspartate and glutamate are not controlled identically under all conditions. Of the compounds studied in the release experiments, the three most likely neurotransmitter candidates are aspartate, glutamate, and GABA. Earlier studies have dealt with the localization of GABA through uptake and autoradiography (Hokfelt and Ljundahl, 1972; Chronwall and Wolff, 1978; Davis et al., 1977) and through immunohistochemical localization of the GABA synthetic enzyme glutamic acid decarboxylase (Ribak, 1978) . In the present study, we have focused on the localization of cells that may use aspartate and glutamate. Previous attempts have been made to localize these compounds to particular pathways in the central nervous system by making a lesion at the source of a pathway and then looking at the terminal region for decreases in endogenous content, high affinity uptake, and release (Nadler et al., 1976; LundKarlsen and Fonnum, 1978) . Cellular localization of particular neurons using these compounds as transmitters, however, has been difficult. It is possible to visualize terminals that take up L-glutamate with high affinity using electron microscopic autoradiography (Storm-Mathiesen and Iversen, 1979) , but the labeling of cell bodies with L-glutamate or L-aspartate is more difficult, possibly because metabolism of the amino acid takes place before sufficient label is transported to them. The D forms of these amino acids, however, when taken up are not metabolized.
D-[3H]
Aspartate, which is accumulated by the same high affinity mechanism that is responsible for uptake of L-aspartate and L-glutamate (Davies and Johnston, 1976) , thus can be used to label cells even after the long survival times required for retrograde labeling of long pathways (Streit and Cuenod, 1979; Beaudet et al., 1980; Streit, 1980) . Although D-glutamate is not taken up as readily by the high affinity mechanism, it may still be possible to use it as a tracer for cellular localization. Release and uptake experiments provide two independent lines of evidence suggesting the role of a compound in neurotransmission. It is important, however, to establish that the release and uptake are localized to the same cells. Previous experiments indicate that D-C3H]aspartate accumulated by the high affinity uptake system can be released with depolarization in a calcium-dependent manner, suggesting that, for this compound, the uptake process does label the same pool that is used for release (Malthe-Sorenssen et al., 1979) .
We have made use of retrograde labeling, as well as local injections and anterograde labeling, to demonstrate that, in visual cortex, accumulation of aspartate and glutamate is particularly associated with layer 6 pyramidal cells that participate in the recurrent projection to the LGN. These cells possess extensive axonal ramifications in layer 4 as well as in layer 6 (Gilbert and Wiesel, 1979) . Given this, one might expect diffuse labeling to occur in layer 4, as is indeed the case. There is, however, another possible explanation for the band of diffuse label in layer 4, which is filling of the terminals of the LGN principal neurons either by anterograde transport following injections in the LGN or by direct uptake following local injections in -cortex. Although we have no evidence to distinguish definitively between these two possibilities, several results suggest that the band, in fact, is derived from the collaterals of layer 6 cell axons. First, if one makes an injection of D-[3H]aspartate in area 17 and looks in the LGN, there are no labeled cell bodies, btit there is a patch of diffuse label at the topographically appropriate site. This demonstrates that (a) the LGN principal cells do not transport t!le label retrogradely from the cortex to their perikarya in the LGN and (b) the layer 6 cells, when labeled by a cortical injection, apparently are able to transport the label anterogradely to their terminals in the LGN. This, in turn, suggests, respectively, that (a) the LGN terminals in the cortex do not take up the label and (b) the layer 6 cells, when labeled retrogradely by an LGN injection, should be able further to transport the label anterogradely to their collaterals in layer 4. Secondly, if one examines the local labeling pattern following an injection into the LGN, once again there is only diffuse labeling with an absence of labeled cell bodies. This indicates that, in the LGN, the principal cells do not accumulate the label and, therefore, presumably cannot transport it to their terminals in layer 4 in the cortex. These results also suggest that anterograde transport may complement retrograde transport in the mapping of transmitter-specific pathways in the brain. In this regard, it is of interest that anterograde labeling with D-[3H]aspartate also has been demonstrated in part of the retinotectal pathway in the pigeon (Beaudet et al., 1980) . Although the corticogeniculate pathway was labeled readily both anterogradely and retrogradely, neither approach produced any sign of labeling in the layer 5 cells participating in the corticocollicular pathway. From previous studies, it has been suggested that, for both the corticogeniculate and corticocollicular pathways, the transmitter is glutamate (Lund-Karlsen and Fonnum, 1978) . This suggestion is based on the finding that, following cortical ablation, the endogenous level of glutamate, but not of aspartate, decreases in both the geniculate and colliculus. The fact that we do not observe labeling of layer 5 cells after collicular injections casts doubt on the idea that this pathway uses glutamate as its transmitter. It is conceivable that we did not find the appropriate conditions to observe the labeling, but this is unlikely since a range of injection volumes and survival times were tried. At the injection sites in the superior colliculus, we did see many labeled cells, and it is possible that the changes in endogenous glutamate levels ob- served after cortical ablation are associated with transsynaptic effects in these cells. Another possibility is that there is a species difference between cats, used in the present labeling of pathways, and rats, used in the cortical ablation experiments, although this also seems unlikely. The release results, furthermore, clearly indicate that some cells in the cortex do release aspartate, and taken together with local cortical injections of D-[~H]-aspartate, they suggest that the layer 6 cells are likely candidates for at least part of the endogenous aspartate release.
Throughout we have used the terms "uptake" and "transport" or "filling" to describe the process by which the cells are labeled following injections of D-[3H]aspartate and D-[3H]glutamate. In fact, the results described give no evidence as to whether there is net uptake of aspartate or glutamate, as opposed to some form of exchange, or whether there is an active intracellular transport process, as opposed to passive diffusion. Regarding the uptake process, it is of interest to note that labeling with D-[3H]aspartate, which, as described earlier, is taken up by the high affinity uptake system, appears to be more efficient than labeling with D-[3H]glutamate, which does not interact as well with the high affinity system. In the present experiments, the distribution of the labeled cells in cortical layer 6 seen after injections of D-["H]glutamate in the LGN and that seen after D-[~H]-aspartate injections were similar, but we have no evidence to indicate whether or not the same cells are labeled by both compounds.
With respect to the mechanism of intracellular translocation of the labeled compounds, we have found that, for successful filling, post-injection survival times are required that are long enough for passive diffusion to play a significant role. For example, following injections in the LGN, survival times of 24 hr gave satisfactory filling in cortical layer 6 cells located about 2 cm away. From cytoplasmic diffusion coefficients measured for GABA and acetylcholine (Koike and Nagata, 19791 , at a site 2 cm from the region of initial labeling, the cytoplasmic concentration of the label at 24 hr should equal approximately 10% of that initially present at the site of injection. It is difficult to estimate the cytoplasmic concentrations of labeled compounds from autoradiographs, but a difference of about lo-fold in exposure times is required to produce a similar labeling density in the cortex and at the injection site in the LGN. Passive diffusion thus could account for a large part of the Vol. 
